Ngo, Benjamin <br/><br/>
Tumor necrosis factor blockade for treatment of inflammatory bowel disease: efficacy and safety.  [electronic resource] 

 -  Current molecular pharmacology  Nov 2010 
 - 145-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1874-4702 
<br/><br/><label>Standard No.: </label>10.2174/1874467211003030145  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Anti-Inflammatory Agents--adverse effects<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Certolizumab Pegol<br/>Clinical Trials as Topic<br/>Humans<br/>Immunoglobulin Fab Fragments--therapeutic use<br/>Inflammatory Bowel Diseases--drug therapy<br/>Infliximab<br/>Polyethylene Glycols--therapeutic use<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors